准分子信号通路和细胞因子反应来调节急性髓性白血病中的c-MYC
Kyle Gu1, Harry A May1,2,3, Min H Kang1,2,3,4
1School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Frontiers in bioscience (Scholar edition)
|September 30, 2024
概括
过度表达MYC瘤基因导致急性髓性白血病 (AML) 和耐药性. 本综述探讨了针对克服MYC驱动的AML的途径的间接治疗策略,从而改善患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- MYC瘤基因 (c-MYC) 在急性髓性白血病 (AML) 病原和耐药性方面至关重要.
- 针对AML的标准化疗结果不理想,需要新的治疗方法.
- 针对FLT3突变和CD33表达等失调的途径是AML治疗的关键.
研究的目的:
- 审查间接治疗策略,以调节MYC在AML中的过度表达.
- 为了突出FDA批准的药物和AML治疗的新药.
- 总结白血病发生的分子过程和调节c-MYC的剂.
主要方法:
- 关于MYC监管在AML中的文献综述.
- 分析涉及BET,CDK9,PI3K/AKT/mTOR和JAK/STAT通路的机制.
- 检查炎症细胞因子在MYC调节中的作用.
主要成果:
- 通过特定途径对c-MYC的间接向提供了一个有前途的治疗途径.
- 几种新药正在研究AML治疗的有效性和耐受性.
- 了解AML的分子驱动因素对于开发有效疗法至关重要.
结论:
- MYC过度表达是AML进展和治疗失败的重要因素.
- 针对BET,CDK9,PI3K/AKT/mTOR和JAK/STAT等途径可以间接控制c-MYC.
- 新型治疗策略有望通过调节c-MYC来改善AML患者的治疗结果.
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Diversity in Cell Signaling Responses
6.4K
The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity.
Graded and Abrupt Responses
Some signaling systems generate...
Graded and Abrupt Responses
Some signaling systems generate...
6.4K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


